DK160986C - Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse - Google Patents

Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse

Info

Publication number
DK160986C
DK160986C DK175585A DK175585A DK160986C DK 160986 C DK160986 C DK 160986C DK 175585 A DK175585 A DK 175585A DK 175585 A DK175585 A DK 175585A DK 160986 C DK160986 C DK 160986C
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
preparations containing
complexes
fresh
fresh complexes
Prior art date
Application number
DK175585A
Other languages
English (en)
Other versions
DK175585D0 (da
DK175585A (da
DK160986B (da
Inventor
Brian Albert Callingham
Robert Charles Hider
George Kontoghiorghes
Michael Arthur Stockham
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK175585D0 publication Critical patent/DK175585D0/da
Publication of DK175585A publication Critical patent/DK175585A/da
Publication of DK160986B publication Critical patent/DK160986B/da
Application granted granted Critical
Publication of DK160986C publication Critical patent/DK160986C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62Three oxygen atoms, e.g. ascorbic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
DK175585A 1984-04-19 1985-04-18 Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse DK160986C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8410289 1984-04-19
GB848410289A GB8410289D0 (en) 1984-04-19 1984-04-19 Pharmaceutical compositions

Publications (4)

Publication Number Publication Date
DK175585D0 DK175585D0 (da) 1985-04-18
DK175585A DK175585A (da) 1985-10-20
DK160986B DK160986B (da) 1991-05-13
DK160986C true DK160986C (da) 1991-11-11

Family

ID=10559910

Family Applications (1)

Application Number Title Priority Date Filing Date
DK175585A DK160986C (da) 1984-04-19 1985-04-18 Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse

Country Status (15)

Country Link
EP (1) EP0159194B1 (da)
JP (1) JPH0794467B2 (da)
AU (1) AU582153B2 (da)
CA (1) CA1286844C (da)
CY (1) CY1575A (da)
DE (1) DE3579730D1 (da)
DK (1) DK160986C (da)
GB (2) GB8410289D0 (da)
HK (1) HK8091A (da)
IE (1) IE58667B1 (da)
IL (1) IL74949A (da)
NZ (1) NZ211788A (da)
PH (1) PH25348A (da)
SG (1) SG92490G (da)
ZA (1) ZA852830B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
CA1283404C (en) * 1986-07-01 1991-04-23 Shigeru Sanai Cephalosporin compounds, processes for their preparation and antibacterial agents
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
ATE98631T1 (de) * 1988-01-20 1994-01-15 Ciba Geigy Ag Verfahren zur herstellung von komplexverbindungen.
JPH03101676A (ja) * 1989-09-14 1991-04-26 Sansho Seiyaku Co Ltd 2―エトキシメチル―5―ヒドロキシ―γ―ピロン及び同化合物を有効成分とするメラニン生成抑制外用剤
WO1991012822A1 (de) * 1990-03-02 1991-09-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Zubereitungen für die mr-diagnostik
AU6010696A (en) * 1995-06-10 1997-01-09 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
WO2002024196A1 (en) 2000-09-19 2002-03-28 Vitra Pharmaceuticals Limited Iron compositions
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
CN102892415B (zh) 2010-03-23 2016-10-19 维福(国际)股份公司 用于治疗和预防铁缺乏症状及缺铁性贫血的Fe(Ⅲ)配合物化合物
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
TWI510496B (zh) 2011-03-29 2015-12-01 Vifor Int Ag 用於治療及預防鐵缺乏症狀及缺鐵性貧血之Fe(III)錯化合物
EP2714030B1 (de) 2011-05-31 2015-08-12 Vifor (International) AG Fe(iii)-2,4-dioxo-1-carbonyl-komplexverbindungen zur verwendung bei der behandlung und der prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
MX2015007974A (es) 2012-12-21 2016-03-09 Vifor Int Ag Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de la deficiencia de hierro y las anemias por deficiencia de hierro.
CN109071481B (zh) * 2016-03-31 2022-09-30 英国神盾Tx股份有限公司 用于由元素铁产生麦芽酚铁组合物的方法
CN109311837B (zh) * 2016-03-31 2022-09-30 英国神盾Tx股份有限公司 用于由氢氧化亚铁产生麦芽酚铁组合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
EP0094149B1 (en) * 1982-03-24 1986-09-10 National Research Development Corporation Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions

Also Published As

Publication number Publication date
JPH0794467B2 (ja) 1995-10-11
PH25348A (en) 1991-05-13
DK175585D0 (da) 1985-04-18
IL74949A (en) 1988-05-31
DK175585A (da) 1985-10-20
GB8509813D0 (en) 1985-05-22
IE58667B1 (en) 1993-11-03
GB2157686B (en) 1987-12-16
EP0159194B1 (en) 1990-09-19
NZ211788A (en) 1988-06-30
CY1575A (en) 1991-12-20
EP0159194A3 (en) 1986-03-12
CA1286844C (en) 1991-07-23
SG92490G (en) 1991-02-14
EP0159194A2 (en) 1985-10-23
JPS60248696A (ja) 1985-12-09
GB2157686A (en) 1985-10-30
GB8410289D0 (en) 1984-05-31
AU582153B2 (en) 1989-03-16
ZA852830B (en) 1986-12-30
HK8091A (en) 1991-02-01
IE850992L (en) 1985-10-19
AU4141385A (en) 1985-10-24
DE3579730D1 (de) 1990-10-25
DK160986B (da) 1991-05-13

Similar Documents

Publication Publication Date Title
DK288184A (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK359986D0 (da) Phenylethere, fremgangsmaader til fremstilling samt farmaceutiske midler indeholdende disse
DK164868C (da) Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK231687A (da) Heterocykliske forbindelser, deres fremstilling og anvendelse, samt laegemidler indeholdende disse forbindelser
DK160986C (da) Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse
DK85087A (da) Substituerede thienoimidazol-derivater, deres fremstilling, praeparater, indeholdende disse, samt anvendelse deraf
DK409784A (da) Substituerede phenyl-alifatiske isoxaler, fremgangsmaade til fremstilling deraf samt antivirale praeparater indeholdende disse
DK164594C (da) 1,4-dihydro-pyridin-3,5-yl-dicarboxylsyrederivater, farmaceutiske praeparater indeholdende disse derivater samt fremgangsmaade til fremstilling deraf
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK163990C (da) Oxindol-3-carboxamid-derivater og farmaceutiske praeparater indeholdende disse
DK163057C (da) Isoindsolinyl-alkyl-piperaziner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK188286D0 (da) Phenylalkyl-2,3-dihydrobenzofuraner og analoge heraf samt praeparater indeholdende disse forbindelser
DK621486D0 (da) 1-benzensulfonyl-2-oxo-5-alkoxypyrrolidinderivater samt deres fremstilling, anvendelse og praeparater med indhold deraf
DK66086D0 (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK116989A (da) Polypeptider samt farmaceutiske praeparater indeholdende disse forbindelser
DK143188A (da) Farmaceutiske praeparater indeholdende pyranoquinolinforbindelser samt deres anvendelse
DK533087D0 (da) Anthracyklinglykosider, deres fremstilling, mellemprodukter deraf samt praeparater indeholdende disse og deres anvendelse
DK162984C (da) 1-(2-ar-2-halogen-2-ethenyl)-1h-azoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK528285D0 (da) Peptider samt praeparater indeholdende disse
DK307085A (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK191086D0 (da) Benzisoselenazolonylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK21785A (da) Dihydropyridinforbindelser og farmaceutiske praeparater indeholdende disse
DK81185A (da) Carboxicam-enolester-forbindelser og farmaceutiske praeparater indeholdende disse
DK135789D0 (da) 19-thiosubstituerede delta4-androstenderivater samt farmaceutisk praeparat indeholdende disse
DK162092C (da) Basisk substituerede 3-phenyl-quinolin-2-on-derivater, deres fremstilling og anvendelse samt laegemiddel indeholdende disse derivater

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK